GENITAL WART

Clinical trials for GENITAL WART explained in plain language.

Never miss a new study

Get alerted when new GENITAL WART trials appear

Sign up with your email to follow new studies for GENITAL WART, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New 15-Valent HPV vaccine trial aims to broaden cancer protection

⭐️ VACCINE ⭐️ Recruiting now

This study tests a new 15-valent HPV vaccine to see if it is safe and triggers a strong immune response. It involves 330 healthy Chinese volunteers aged 9 to 45. Participants receive three doses of the vaccine or a placebo, and researchers monitor side effects and antibody levels…

Matched conditions: GENITAL WART

Phase: PHASE2 • Sponsor: Shanghai Bovax Biotechnology Co., Ltd. • Aim: ⭐️ VACCINE ⭐️

Last updated May 13, 2026 16:02 UTC

GENITAL WART

Get alerted when new GENITAL WART trials appear

New 15-Valent HPV vaccine trial aims to broaden cancer protection